Press Release: GTCR Announces US$200 Million Preferred Equity Investment to Support Acquisition of Workplace Options by TELUS Health

Dow Jones
Yesterday
GTCR Announces US$200 Million Preferred Equity Investment to Support 
Acquisition of Workplace Options by TELUS Health 
 
 
   PR Newswire 
 
 
   CHICAGO, May 14, 2025 
 
 
   Acquisition of Workplace Options to Enhance TELUS Health's Global Reach 
and Technology Platform for Employee Assistance Programs 
 
 
   CHICAGO, May 14, 2025 /PRNewswire/ -- GTCR, a leading private equity 
firm, announced today that it has simultaneously signed and closed a 
definitive agreement to provide a strategic, structured minority 
investment to support TELUS Health's recently announced acquisition of 
Workplace Options (WPO). TELUS Health is a leading global provider of 
payor technology, pharmacy management technology, electronic medical 
records and supplemental benefits for providers, payors, employers and 
enterprise customers. TELUS Health's portfolio of products and services 
enables customers globally to integrate technology to improve healthcare 
delivery and patient outcomes across the healthcare ecosystem. In 2024, 
TELUS Health generated revenue of CAD $1.8 billion. The preferred equity 
investment is associated with the acquisition of WPO, which is highly 
complementary to TELUS Health's current offering, expanding the 
Company's geographic reach, adding to its breadth of service offerings 
and investing in additional technology platforms. 
 
 
 
   TELUS Health's acquisition of WPO reinforces the company's thesis in 
building a scaled, global provider of health and wellbeing products and 
services that improves health outcomes. The acquisition allows TELUS 
Health to expand its service offerings to existing customers, extend its 
geographic reach and strengthen its current technology platform. TELUS 
Health expects to realize commercial synergies through cross-selling 
channels and improved go-to-market strategies. The investment aligns 
well with GTCR's strong track record investing across healthcare, 
corporate partnerships and structured minority investments. We view this 
transaction as an excellent opportunity for TELUS Health to leverage our 
historical expertise with a new value-add partner in support of their 
mission to grow and scale globally in the employer-funded healthcare 
space. 
 
 
   "We are thrilled to partner with TELUS Health in its acquisition of WPO 
to support its continued growth in the healthcare sector, where we have 
deep domain expertise," said Dean Mihas, GTCR co-CEO and Managing 
Director. "TELUS Health's innovative approach to healthcare technology 
and its commitment to improving patient outcomes aligns very well with 
GTCR's investment philosophy." 
 
 
   "We are pleased to structure a bespoke transaction to meet the needs of 
our partner," said Jason Prager, Managing Director. "Providing flexible 
preferred equity and debt capital solutions to outstanding management 
teams, coupled with strategic partnership and insights to drive value 
creation, is core to GTCR's approach to delivering value to our 
portfolio companies, investors and other stakeholders." 
 
   About TELUS Health 
 
 
   TELUS Health is on a mission to become the most trusted wellbeing 
company in the world by enhancing the overall efficiency of healthcare 
and championing workplace wellbeing. By integrating advanced healthcare 
technology with comprehensive employee support services, TELUS Health 
provides a holistic approach to primary and preventive health and 
wellbeing, enhancing more than 150 million lives across more than 200 
countries and territories. Our innovative digital health platforms, 
including electronic medical records (EMRs) and virtual care solutions, 
empower healthcare professionals, employers and governments to deliver 
personalized care efficiently. Our employee wellbeing programs empower 
individuals by offering extensive support through Employee and Family 
Assistance Programs (EFAPs), mental health resources, financial 
counselling and workplace wellness initiatives. At TELUS Health, we are 
committed to revolutionizing healthcare to ensure people receive the 
support they need and employees thrive both personally and 
professionally. Together, let's make the future friendly. For more 
information please visit: www.telushealth.com. 
 
   About GTCR 
 
 
   Founded in 1980, GTCR is a leading private equity firm that invests 
behind The Leaders Strategy(TM) -- finding and partnering with 
management leaders in core domains to identify, acquire and build 
market-leading companies through organic growth and strategic 
acquisitions. GTCR is focused on investing in transformative growth in 
companies in the Business & Consumer Services, Financial Services & 
Technology, Healthcare and Technology, Media & Telecommunications 
sectors. Since its inception, GTCR has invested more than $30 billion in 
over 280 companies, and the firm currently manages $45 billion in equity 
capital. GTCR is based in Chicago with offices in New York and West Palm 
Beach. For more information, please visit www.gtcr.com. Follow us 
on LinkedIn. 
 
   GTCR Media Contact: 
 
   Josh Clarkson / Ryan Smith 
 
   212-279-3115 
 
 
   pro-GTCR@Prosek.com 
 
   TELUS Health Media Contact: 
 
   Marielle Hossack 
 
 
   marielle.hossack@telus.com 
 
 
    View original content to download 
multimedia:https://www.prnewswire.com/news-releases/gtcr-announces-us200-million-preferred-equity-investment-to-support-acquisition-of-workplace-options-by-telus-health-302455350.html 
 
 
 
   SOURCE GTCR 
 
 
 
 
 
 

(END) Dow Jones Newswires

May 14, 2025 09:30 ET (13:30 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10